Latest Content

Dr. Jennifer Amengual explains how epigenetic therapies treat lymphomas by changing gene expression rather than killing dividing cells like chemotherapy.

Personalized treatment, exercise and supportive care improve outcomes for patients with metastatic hormone-sensitive prostate cancer.

Dr. Don S. Dizon presented information on pregnancy with a breast cancer diagnosis and what patients should know.

Studies show Signatera ctDNA testing may predict recurrence and guide treatment decisions in anal and rectal cancers.

The CAPTAIN trial shows MRI-guided TULSA preserved erectile and urinary function versus surgery in localized prostate cancer.

A daughter’s cancer journey shows that survivorship is filled with constant waiting—from tests and treatment to life milestones — where each result can bring relief or fear.

Learn about male breast cancer, including common symptoms, diagnostic tests and how hormone therapy or surgery is used to treat this rare disease.

Stage 1 mixed cellularity Hodgkin lymphoma is often highly treatable with chemotherapy and radiation, with additional therapies available if the disease returns.

A colorectal cancer survivor shares what life with an ostomy is really like, offering advice and reassurance for patients adjusting after surgery.

Dr. Anastasia Tousimis explores the feasibility, risks and surgical techniques for performing NSM in radiated patients to ensure oncologic safety.

That’s what I need to remember: Not made-up scenarios, but that if I’m open, truly open, to whatever life has in store, it will be OK.

Keytruda plus weekly paclitaxel improved overall and progression-free survival in platinum-resistant ovarian cancer in the phase 3 KEYNOTE-B96 trial.

A study of 922 patients shows the Aida test predicts 10-year recurrence risk and helps guide radiation decisions for invasive breast cancer.